ArticleClinical and translational medicine2021

Inhibition of HSC70 alleviates hypertrophic cardiomyopathy pathology in human induced pluripotent stem cell-derived cardiomyocytes with a MYBPC3 mutation.

Hangyuan Qiu et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.